Results 11 to 20 of about 15,859 (208)

Radiotherapy of Oligometastatic Cancers

open access: yesCancers
The enhanced multidisciplinary treatment approach and the widespread use of advanced imaging techniques have led to an improvement in survival rates, inevitably associated with an increase in the number of oligometastatic diagnoses in cancer patients [...]
Filippo Alongi, Simona Gaito
openaire   +3 more sources

Chemotherapy for oligometastatic prostate cancer

open access: yesCurrent Opinion in Urology, 2017
To analyze recent trials of upfront chemotherapy to determine how this paradigm can be applied to oligometastatic prostate cancer patients.Upfront chemotherapy prolongs survival in metastatic prostate cancer, according to the ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer and STAMPEDE docetaxel ...
Tanya B, Dorff, Christopher J, Sweeney
openaire   +3 more sources

Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases

open access: yesFrontiers in Endocrinology
Purpose/objective(s)Biomarkers for extracranial oligometastatic disease remain elusive and few studies have attempted to correlate genomic data to the presence of true oligometastatic disease.MethodsPatients with non-small cell lung cancer (NSCLC) and ...
Ariel R. Choi   +18 more
doaj   +2 more sources

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. [PDF]

open access: yes, 2022
BACKGROUND Consensus about the definition and treatment of oligometastatic oesophagogastric cancer is lacking. OBJECTIVE To assess the definition and treatment of oligometastatic oesophagogastric cancer across multidisciplinary tumour boards ...
Roviello, Franco   +472 more
core   +15 more sources

Oligometastatic non-small-cell lung cancer: current treatment strategies

open access: yesLung Cancer: Targets and Therapy, 2016
Patrick J Richard, Ramesh Rengan Department of Radiation Oncology, University of Washington, Seattle, WA, USA Abstract: The oligometastatic disease theory was initially described in 1995 by Hellman and Weichselbaum.
Richard PJ, Rengan R
doaj   +1 more source

Estimating the Prevalence of a True Oligometastatic Disease

open access: yesCancers, 2022
To delineate a patient group with few distant metastases that could possibly benefit from a curative therapeutic strategy employing a local approach, the term oligometastatic disease (OMD) was introduced into the clinical practice almost 30 years ago [...]
Petr Szturz   +2 more
openaire   +6 more sources

Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors. [PDF]

open access: yesCancer Med
ABSTRACT Background Local therapy has recently been applied to treat oligometastatic cancer across various malignant cancers. However, definitive evidence for local treatment regimens remains lacking. We aimed to evaluate the clinical outcomes of combining local therapy with systemic treatment for patients with oligometastatic solid tumors including ...
Deng X   +6 more
europepmc   +2 more sources

Imaging of Oligometastatic Disease [PDF]

open access: yesCancers, 2022
Oligometastatic disease (OMD) is an emerging state of disease with limited metastatic tumor burden. It should be distinguished from polymetastatic disease due the potential curative therapeutic options of OMD. Imaging plays a pivotal role in the diagnosis and follow-up of patients with OMD.
Naik Vietti Violi   +5 more
openaire   +3 more sources

Prostate cancer - what about oligometastatic disease and stereotactic ablative radiotherapy? - a narrative review [PDF]

open access: yes, 2023
Oligometastatic prostate cancer (OMPC) encompasses a heterogenous group of clinical entities defined by the timing of the development of metastases. These include de novo oligometastatic, oligorecurrent and oligoprogressive prostate cancer (PrCa).
Helen Saxby   +8 more
core   +3 more sources

Oligometastatic Prostate Cancer [PDF]

open access: yesKlinicka Onkologie, 2019
With advancements in diagnostic techniques, oligometastatic prostate cancer is diagnosed in patients who were, in the past, considered to have localized disease. Moreover, evidence of the effectiveness of treatment intensification for this disease is increasing, focusing on primary tumors as well as metastatic lesions.
J, Navrátil   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy